Chen J, Jin Z, Zhang S, Zhang X, Li P, Yang H, et al
For all industry stakeholderswhether operating in the compounding and telehealth space or holding approved NDAs and ANDAsthe message is clear: FDA intends to maintain a bright line between compounded and approved drugs, and companies should review their marketing materials, monitor enforcement developments, and prepare for additional waves of enforcement action
Diabetologia 61, 919931
2009, 8: 28- 10.1186/1475-2859-8-28 Rudi V, Melanie P, Matthias E, Arnim W, Heiko L, Stefanie O, Sonja V, Angel A, Georg B, Wolfgang L: Genomic analysis reveals Lactobacillus sanfranciscensis as stable element in traditional sourdoughs
Among people who did have a history of substance abuse, those who got a GLP-1 drug had a 25% to 50% lower risk for emergency departments visits, hospitalization, drug overdose, suicidal thoughts or attempts, and death